switching between tirzepatide and semaglutide Transitioning Treatments: What to Expect When Changing from to Switching Semaglutide to Tirzepatide |

The landscape differs substantially between the FDA-approved Mounjaro and the investigational Retatrutide

It is mainly prescribed to promote weight loss in people who are overweight or who have obesity

It activates both GLP-1 and GIP receptors, which is one reason it tends to produce larger weight reductions than semaglutide

Loren Pickart from human plasma, and since then it has been the subject of more than 200 published studies spanning wound healing, dermatology, hair biology, gene expression, and most recently, longevity research

Both are designed to support weight loss, appetite control, blood sugar regulation, and overall metabolic health, but they work differently inside the body